Clinical Trials

Stomach Neoplasms

NCT06356311 2026-02-27

TroFuse-015

450 enrolled

Adenocarcinoma Of Esophagus

NCT05198934 2026-02-06

CodeBreak300

160 enrolled 1 FDA

Colorectal Neoplasms

NCT04776148 2026-02-05

MK-7902-017

563 enrolled 32 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04457297 2026-01-21

ALTAIR

243 enrolled 13 charts

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT05064059 2025-09-17

MK-4280A-007

441 enrolled 24 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT06614192 2025-08-26

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

Phase 3 Recruiting

460 enrolled

Colorectal Neoplasms

NCT05328908 2025-08-13

RELATIVITY-123

Phase 3 Terminated

770 enrolled

Spinocerebellar Degenerations, Colorectal Neoplasms

NCT04879368 2025-07-17

INTEGRATEIIb

450 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT06199973 2025-07-17

Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan

130 enrolled

Phase 3 Not yet recruiting

Advanced Colorectal Cancer

NCT06850090 2025-06-25

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

210 enrolled

Rectal Neoplasms

NCT04737187 2024-09-24

SUNLIGHT

492 enrolled 22 charts 1 FDA

Colorectal Neoplasms

NCT01607957 2024-09-19

RECOURSE

800 enrolled 12 charts

Colorectal Neoplasms

NCT02500043 2024-09-03

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

507 enrolled 17 charts 1 FDA

Stomach Neoplasms

NCT05223673 2024-08-20

COLSTAR

Phase 3 Terminated

7 enrolled 12 charts

Phase 3 Not yet recruiting

Neoplasm Metastasis, Colorectal Neoplasms

NCT06343116 2024-04-02

NOTABLE-308

420 enrolled

Colorectal Neoplasms

NCT01955837 2020-11-17

TERRA

406 enrolled 22 charts

Colorectal Neoplasms

NCT03717038 2019-02-04

Sym004 Versus TAS-102 in Patients With mCRC

Phase 3 Withdrawn